Preparation of Microspheres and Incorporation of Lipid Hydroperoxide for Sustained Release Studies

互联网2014-02-13

301

The development of controlled-release drug-delivery systems that can achieve an effective concentration for a specific period has been investigated using various drug carriers (1 ).

相关产品推荐

GSPT1/GSPT1蛋白/G1 to S phase transition protein 1 homolog ERF3A蛋白/Recombinant Human Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)重组蛋白

￥69

LTP2/LTP2蛋白/Allergen Par j II Major pollen allergen Par j 2.0101 Protein P2 Allergen: Par j 2.0101蛋白/Recombinant Parietaria judaica Probable non-specific lipid-transfer protein 2 (LTP2)重组蛋白

￥69

RYR3/RYR3蛋白Recombinant Human Ryanodine receptor 3 (RYR3)重组蛋白Brain ryanodine receptor-calcium release channelBrain-type ryanodine receptorType 3 ryanodine receptor蛋白

￥1344

GSPT1/GSPT1蛋白Recombinant Human Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)重组蛋白GSPT1蛋白

￥2208

RYR1/RYR1蛋白Recombinant Human Ryanodine receptor 1 (RYR1)重组蛋白(RYR-1)(RyR1)(Skeletal muscle calcium release channel)(Skeletal muscle ryanodine receptor)(Skeletal muscle-type ryanodine receptor)(Type 1 ryanodine receptor)蛋白

￥2328